There is a national shortage of some Attention Deficit Hyperactivity Disorder (ADHD) medicines including Lisdexamfetamine, Methylphenidate, Guanfacine and Atomoxetine. We are expecting the supply issues to be short-lived and are monitoring…
Read More
